Greiner Bio-One subsidiary Mediscan opens a new sterilisation facility
Bild: © Roland Pelzl
Mediscan, a sterilisation service provider and subsidiary of Greiner Bio-One International GmbH, has built and officially opened a new sterilisation facility at its Kremsmünster/Rohr site.
Kremsmünster, November 2024 – Sterilisation service provider Mediscan, headquartered in Kremsmünster, has built a new facility adjacent to its existing site to sterilise medical products, disinfect food packaging, and refine plastics and semiconductors. The company has invested a total of €22 million and, in addition to the construction of the new building, the facility includes a powerful electron accelerator and highly automated conveyor technology. The facility, which had been in trial operation since August, was officially opened on 13 November.
“Mediscan’s sterilisation service is an integral part of the production chain of many products and is often an undervalued part of the manufacturing process. I am proud that we have outstanding specialists who ensure safe sterilisation to the highest standards and, as a result, make a big difference to people’s health.”
Increasing demand for sterilisation services
Since the last site expansion in 2015, the production volumes of Greiner Bio-One and the demand for sterilisation services have continued to increase. Mediscan treats the manufactured medical devices before they are delivered to customers worldwide. However, demand from third-party customers, not just from the medical sector, but also from the food, automotive and electronics industries, now plays an increasingly important role. Mediscan currently generates around 70 percent of its turnover from demand from third-party customers.
“With the newly created capacities, Mediscan in Kremsmünster is developing into the largest sterilisation site in Europe. The expansion has also created further capacities in order to meet the demands of new third-party customers.”
State-of-the-art technology and expertise
The system technology used meets the latest standards. It has undergone further technological development compared to the initial site and once again combines two different treatment technologies in a single system. The electrons accelerated in an electron accelerator are used either directly as electron beams (E-beams) or indirectly after conversion to X-ray photons (X-rays) to sterilise and disinfect products. This means that individual product requirements can be met with the highest accuracy and quality.
Commitment to the Upper Austria site
Also in the field of sterilisation services, the international market environment is characterised by sharp price increases and limited availability. This makes it all the more important for Greiner Bio-One to ensure this service for its products and thus the supply of its customers.
“We are very proud of the development of the Greiner Bio-One subsidiary Mediscan: a lot of expertise is bundled up there and we think it has great potential for the future. With this capacity expansion, we at Greiner also want to make a clear commitment to our business location in Upper Austria.”
